Kala Bio Inc (KALA)
7.007
+0.25
(+3.74%)
USD |
NASDAQ |
May 03, 16:00
6.83
-0.18
(-2.53%)
After-Hours: 20:00
Kala Bio Total Assets (Quarterly): 55.95M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 55.95M |
| September 30, 2023 | 61.12M |
| June 30, 2023 | 66.50M |
| March 31, 2023 | 72.23M |
| December 31, 2022 | 86.82M |
| September 30, 2022 | 85.70M |
| June 30, 2022 | 84.98M |
| March 31, 2022 | 111.57M |
| December 31, 2021 | 139.43M |
| September 30, 2021 | 193.81M |
| June 30, 2021 | 215.46M |
| March 31, 2021 | 229.83M |
| December 31, 2020 | 221.61M |
| September 30, 2020 | 225.10M |
| June 30, 2020 | 245.51M |
| Date | Value |
|---|---|
| March 31, 2020 | 258.53M |
| December 31, 2019 | 154.32M |
| September 30, 2019 | 161.01M |
| June 30, 2019 | 178.82M |
| March 31, 2019 | 197.02M |
| December 31, 2018 | 220.97M |
| September 30, 2018 | 84.08M |
| June 30, 2018 | 95.59M |
| March 31, 2018 | 104.99M |
| December 31, 2017 | 116.55M |
| September 30, 2017 | 123.69M |
| June 30, 2017 | 28.59M |
| March 31, 2017 | 37.61M |
| December 31, 2016 | 46.33M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
55.95M
Minimum
Dec 2023
258.53M
Maximum
Mar 2020
149.91M
Average
154.32M
Median
Dec 2019
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 28.71M |
| AIM ImmunoTech Inc | 19.38M |
| IGC Pharma Inc | 11.26M |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Protalix BioTherapeutics Inc | 84.43M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 48.44M |
| Shareholders Equity (Quarterly) | 7.504M |